The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis

Clinical trial NCT00329680 · COMPLETED

Trial details

NCT number: NCT00329680
Sponsor: Fernandes Tavora Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Sepsis Severe Sepsis Septic Shock

Start date: 2007-06-01
Primary completion: 2008-12-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.